BioStrategic Consulting Ltd provides a range of management-level clinical development consulting services to the pharmaceutical, biotechnology and medical device industries, including:• Clinical development strategy and management, especially for development-stage companies • Conceptualization, implementation, and management of Phase 1, Phase 2, first-in-man, and proof-of principle clinical trials• IND planning and preparation• FDA and other regulatory authority submissions, meetings, and related interactions• Clinical strategic planning for small molecules, biotechnology products, immunotherapeutic agents, novel drug delivery technologies, and medical devices in virtually all therapeutic areas• New technology assessment, due diligence, and program planning• Clinical development advisory services to senior-level management (CEO, COO, CSO, BOD).